BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/08/2007

FDA Clears PHOSLO Calcium Acetate 667-mg Tablet for Approval

The FDA has ruled that PHOSLO (calcium acetate) 667-mg tablet, containing 169 mg of calcium, was not withdrawn from sale due to safety or efficacy concerns, paving the way for the approval of abbreviated new drug applications (ANDAs) for this product.

Source: Federal Register — Food and Drug AdministrationOpen original release →